Sangamo Therapeutics Enters Capsid License Agreement With Lilly
Genomic medicine company Sangamo Therapeutics said it entered a license agreement with Eli Lilly, under which Lilly received rights to employ Sangamo's proprietary capsid, STAC-BBB, for up to five ...
Here’s how Trump’s tariffs could fuel trillions in new tax cuts, and why they could be here to stay
President Donald Trump has long championed tariffs and railed against America’s trade deficits. But his latest trade-war ...
Recession fears roil U.S. markets after Trump’s tariffs. What investors need to hear from Fed’s Powell on Friday.
Fed Chair Jerome Powell’s remarks and the March nonfarm-payroll report on Friday will need to deliver for a stock market ...
FDA Approves Second Indication for Amgen's Immune System Treatment Uplizna
Amgen said the Food and Drug Administration approved Uplizna for Immunoglobulin G4-related disease, the second approved indication. The biotechnology company said Thursday the FDA granted breakthrough ...
S&P 500 logs worst daily plunge since 2020
Stocks closed sharply lower on Thursday as President Donald Trump's latest tariffs rocked Wall Street, with the S&P 500 posting its worst daily drop since mid-2020, according to Dow Jones Market Data.
Trump administration eyes changes to student-loan repayment plans
It’s too early to know how the changes will impact borrowers, but the announcement will come amid confusion surrounding ...
2-, 10-year Treasury yields end at lowest since October as Trump tariff plans rattle markets
Thursday's flight to safety in U.S. government debt, triggered by economic-growth concerns a day after President Donald Trump announced his latest tariff plans, sent 2- and 10-year yields to their ...
Brazil ETF on track for gain after escaping worst of Trump tariffs
Brazilian stocks were among the few global bright spots Thursday. The iShares MSCI Brazil ETF was up 0.7% amid a global stock ...